BMRN logo

BioMarin Pharmaceutical (BMRN) Cost Of Goods Sold

Annual Cost Of Goods Sold

$514.85 M
+$31.18 M+6.45%

31 December 2023

1-Year Change

+6.45%
BMRN annual cost of goods sold is up +6.45% year-on-year

3-Year Change

-1.8%
BMRN annual cost of goods sold is down -1.8% over the past 3 years

All-time High

$524.27 M
BMRN annual cost of goods sold is currently -1.80% below its historical high of $524.27 million

Sector Rank

77.13%
BMRN annual cost of goods sold is higher than 77.13% of companies in Healthcare sector
Annual Revenue$2.42 B
BMRN annual revenue is $2.42 billion
Annual Gross Profit$1.90 B
BMRN annual gross profit is $1.90 billion
Annual Operating Profit$158.10 M
BMRN annual operaing income is $158.10 million
Annual Net Income$167.65 M
BMRN annual net profit is $167.65 million

BMRN Cost Of Goods Sold Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Cost Of Goods Sold

$188.46 M
+$58.00 M+44.46%

30 September 2024

1-Year Change

+47.18%
BMRN quarterly cost of goods sold is up +47.18% year-on-year

3-Year Change

+82.02%
BMRN quarterly cost of goods sold is up +82.02% over the past 3 years

All-time High

$188.79 M
BMRN quarterly cost of goods sold is currently -0.18% below its historical high of $188.79 million

Sector Rank

79.65%
BMRN quarterly cost of goods sold is higher than 79.65% of companies in Healthcare sector
Quarterly Revenue$745.74 M
BMRN quarterly revenue is $745.74 million
Quarterly Gross Profit$557.28 M
BMRN quarterly gross profit is $557.28 million
Quarterly Operating Profit$113.89 M
BMRN quarterly operating income is $113.89 million
Quarterly Net Income$106.08 M
BMRN quarterly net profit is $106.08 million

BMRN Quarterly Cost Of Goods Sold Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Cost Of Goods Sold

$564.82 M
+$60.42 M+11.98%

30 September 2024

1-Year Change

+8.32%
BMRN TTM cost of goods sold is up +8.32% year-on-year

3-Year Change

+18.43%
BMRN TTM cost of goods sold is up +18.43% over the past 3 years

All-time High

$564.82 M
BMRN TTM cost of goods sold is currently at an all-time high

Sector Rank

76.81%
BMRN TTM cost of goods sold is higher than 76.81% of companies in Healthcare sector
TTM Revenue$2.75 B
BMRN TTM revenue is $2.75 billion
TTM Gross Profit$2.19 B
BMRN TTM gross profit is $2.19 billion
TTM Operating Profit$327.09 M
BMRN TTM operating income is $327.09 million
TTM Net Income$322.29 M
BMRN TTM net profit is $322.29 million

BMRN TTM Cost Of Goods Sold Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BMRN Cost Of Goods Sold Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.5%+47.2%+8.3%
3 y3 years-1.8%+82.0%+18.4%
5 y5 years+63.3%+94.4%+66.8%

BMRN Cost Of Goods Sold High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-1.8%+9.4%at high+82.0%at high+21.9%
5 y5 years-1.8%+63.3%-0.2%+96.5%at high+66.8%
alltimeall time-1.8%>+9999.0%-0.2%>+9999.0%at high>+9999.0%

BioMarin Pharmaceutical Cost Of Goods Sold History

DateAnnualQuarterlyTTM
Sept 2024
-
$188.46 M(+44.5%)
$564.82 M(+12.0%)
June 2024
-
$130.46 M(+4.2%)
$504.40 M(-0.0%)
Mar 2024
-
$125.18 M(+3.7%)
$504.56 M(-2.0%)
Dec 2023
$514.85 M(+6.4%)
$120.72 M(-5.7%)
$514.85 M(-1.3%)
Sept 2023
-
$128.04 M(-2.0%)
$521.42 M(+2.3%)
June 2023
-
$130.62 M(-3.6%)
$509.67 M(+1.5%)
Mar 2023
-
$135.47 M(+6.4%)
$502.18 M(+3.8%)
Dec 2022
$483.67 M(+2.8%)
$127.29 M(+9.5%)
$483.67 M(+1.6%)
Sept 2022
-
$116.29 M(-5.6%)
$476.13 M(+2.8%)
June 2022
-
$123.13 M(+5.3%)
$463.38 M(-0.8%)
Mar 2022
-
$116.97 M(-2.3%)
$467.31 M(-0.7%)
Dec 2021
$470.51 M(-10.3%)
$119.75 M(+15.7%)
$470.51 M(-1.3%)
Sept 2021
-
$103.54 M(-18.5%)
$476.90 M(-15.2%)
June 2021
-
$127.06 M(+5.7%)
$562.16 M(+5.5%)
Mar 2021
-
$120.17 M(-4.7%)
$533.06 M(+1.7%)
Dec 2020
$524.27 M(+45.8%)
$126.14 M(-33.2%)
$524.27 M(+6.1%)
Sept 2020
-
$188.79 M(+92.7%)
$494.03 M(+22.8%)
June 2020
-
$97.97 M(-12.0%)
$402.19 M(+5.4%)
Mar 2020
-
$111.37 M(+16.1%)
$381.66 M(+6.2%)
Dec 2019
$359.47 M(+14.0%)
$95.90 M(-1.1%)
$359.47 M(+6.2%)
Sept 2019
-
$96.95 M(+25.2%)
$338.59 M(+5.6%)
June 2019
-
$77.44 M(-13.2%)
$320.53 M(-0.5%)
Mar 2019
-
$89.18 M(+18.9%)
$322.11 M(+2.2%)
Dec 2018
$315.26 M(+30.4%)
$75.02 M(-4.9%)
$315.26 M(-0.3%)
Sept 2018
-
$78.89 M(-0.2%)
$316.24 M(+6.5%)
June 2018
-
$79.02 M(-4.0%)
$296.83 M(+8.3%)
Mar 2018
-
$82.33 M(+8.3%)
$274.11 M(+13.4%)
Dec 2017
$241.79 M(+15.3%)
$76.00 M(+27.8%)
$241.79 M(+5.2%)
Sept 2017
-
$59.48 M(+5.6%)
$229.94 M(+4.0%)
June 2017
-
$56.30 M(+12.6%)
$221.20 M(+2.2%)
Mar 2017
-
$50.01 M(-22.0%)
$216.51 M(+3.3%)
Dec 2016
$209.62 M(+37.9%)
$64.15 M(+26.4%)
$209.62 M(+8.3%)
Sept 2016
-
$50.74 M(-1.7%)
$193.52 M(+8.9%)
June 2016
-
$51.62 M(+19.7%)
$177.68 M(+8.3%)
Mar 2016
-
$43.12 M(-10.3%)
$164.13 M(+8.0%)
Dec 2015
$152.01 M(+24.3%)
$48.04 M(+37.6%)
$152.01 M(+6.8%)
Sept 2015
-
$34.90 M(-8.3%)
$142.29 M(+3.6%)
June 2015
-
$38.06 M(+22.8%)
$137.30 M(+5.3%)
Mar 2015
-
$31.00 M(-19.1%)
$130.45 M(+6.7%)
Dec 2014
$122.27 M(+38.3%)
$38.32 M(+28.1%)
$122.27 M(+20.8%)
Sept 2014
-
$29.92 M(-4.1%)
$101.22 M(+1.9%)
June 2014
-
$31.21 M(+36.8%)
$99.35 M(+9.5%)
Mar 2014
-
$22.82 M(+32.1%)
$90.71 M(+2.6%)
Dec 2013
$88.39 M
$17.27 M(-38.4%)
$88.39 M(-9.5%)
Sept 2013
-
$28.05 M(+24.3%)
$97.65 M(+3.6%)
DateAnnualQuarterlyTTM
June 2013
-
$22.57 M(+10.1%)
$94.22 M(-1.1%)
Mar 2013
-
$20.50 M(-22.7%)
$95.22 M(+3.7%)
Dec 2012
$91.83 M(+9.3%)
$26.53 M(+7.8%)
$91.83 M(+5.8%)
Sept 2012
-
$24.62 M(+4.4%)
$86.82 M(+2.6%)
June 2012
-
$23.57 M(+37.8%)
$84.64 M(+5.4%)
Mar 2012
-
$17.11 M(-20.5%)
$80.33 M(-4.4%)
Dec 2011
$84.02 M(+19.5%)
$21.52 M(-4.1%)
$84.02 M(+1.3%)
Sept 2011
-
$22.45 M(+16.5%)
$82.97 M(+5.7%)
June 2011
-
$19.26 M(-7.4%)
$78.53 M(+6.6%)
Mar 2011
-
$20.80 M(+1.6%)
$73.67 M(+4.8%)
Dec 2010
$70.28 M(+6.6%)
$20.47 M(+13.7%)
$70.28 M(+5.6%)
Sept 2010
-
$18.00 M(+25.0%)
$66.55 M(+4.8%)
June 2010
-
$14.40 M(-17.3%)
$63.51 M(-7.9%)
Mar 2010
-
$17.41 M(+4.1%)
$68.96 M(+4.6%)
Dec 2009
$65.91 M(+25.5%)
$16.73 M(+11.8%)
$65.91 M(+8.3%)
Sept 2009
-
$14.97 M(-24.6%)
$60.84 M(+1.5%)
June 2009
-
$19.85 M(+38.2%)
$59.94 M(+20.6%)
Mar 2009
-
$14.36 M(+23.1%)
$49.68 M(-5.4%)
Dec 2008
$52.51 M(+186.0%)
$11.66 M(-17.1%)
$52.51 M(+14.0%)
Sept 2008
-
$14.06 M(+46.6%)
$46.07 M(+26.3%)
June 2008
-
$9.59 M(-44.2%)
$36.47 M(+16.0%)
Mar 2008
-
$17.19 M(+229.0%)
$31.43 M(+71.2%)
Dec 2007
$18.36 M(+110.1%)
$5.22 M(+17.1%)
$18.36 M(+9.6%)
Sept 2007
-
$4.46 M(-2.1%)
$16.75 M(+12.4%)
June 2007
-
$4.56 M(+10.7%)
$14.90 M(+33.8%)
Mar 2007
-
$4.12 M(+13.9%)
$11.13 M(+27.4%)
Dec 2006
$8.74 M(+232.4%)
$3.62 M(+38.4%)
$8.74 M(+35.5%)
Sept 2006
-
$2.61 M(+231.1%)
$6.45 M(+61.2%)
June 2006
-
$789.00 K(-54.2%)
$4.00 M(+8.4%)
Mar 2006
-
$1.72 M(+29.7%)
$3.69 M(+40.4%)
Dec 2005
$2.63 M(-33.5%)
$1.33 M(+709.8%)
$2.63 M(-42.9%)
Sept 2005
-
$164.00 K(-65.7%)
$4.61 M(+2.9%)
June 2005
-
$478.00 K(-27.6%)
$4.48 M(-2.9%)
Mar 2005
-
$660.00 K(-80.0%)
$4.61 M(+16.7%)
Dec 2004
$3.95 M(-664.7%)
$3.31 M(+9342.9%)
$3.95 M(+510.0%)
Sept 2004
-
$35.00 K(-94.3%)
$648.00 K(+5.7%)
June 2004
-
$613.00 K(+118.1%)
$613.00 K(+118.1%)
Sept 2001
-
$281.00 K(-116.4%)
$281.00 K(-105.9%)
Sept 2000
-
-$1.71 M(+11.7%)
-$4.80 M(-3.8%)
June 2000
-
-$1.53 M(-1.3%)
-$4.99 M(+9.5%)
Mar 2000
-
-$1.55 M(-18.3%)
-$4.55 M(+17.1%)
Sept 1999
-
-$1.90 M(+72.7%)
-$3.89 M(+95.6%)
June 1999
-
-$1.10 M(+24.0%)
-$1.99 M(+124.0%)
Mar 1999
-
-$887.00 K
-$887.00 K
Dec 1998
-$700.00 K
-
-

FAQ

  • What is BioMarin Pharmaceutical annual cost of goods sold?
  • What is the all time high annual cost of goods sold for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual cost of goods sold year-on-year change?
  • What is BioMarin Pharmaceutical quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly cost of goods sold year-on-year change?
  • What is BioMarin Pharmaceutical TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical TTM cost of goods sold year-on-year change?

What is BioMarin Pharmaceutical annual cost of goods sold?

The current annual cost of goods sold of BMRN is $514.85 M

What is the all time high annual cost of goods sold for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual cost of goods sold is $524.27 M

What is BioMarin Pharmaceutical annual cost of goods sold year-on-year change?

Over the past year, BMRN annual cost of goods sold has changed by +$31.18 M (+6.45%)

What is BioMarin Pharmaceutical quarterly cost of goods sold?

The current quarterly cost of goods sold of BMRN is $188.46 M

What is the all time high quarterly cost of goods sold for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly cost of goods sold is $188.79 M

What is BioMarin Pharmaceutical quarterly cost of goods sold year-on-year change?

Over the past year, BMRN quarterly cost of goods sold has changed by +$60.42 M (+47.18%)

What is BioMarin Pharmaceutical TTM cost of goods sold?

The current TTM cost of goods sold of BMRN is $564.82 M

What is the all time high TTM cost of goods sold for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high TTM cost of goods sold is $564.82 M

What is BioMarin Pharmaceutical TTM cost of goods sold year-on-year change?

Over the past year, BMRN TTM cost of goods sold has changed by +$43.40 M (+8.32%)